Clinical analysis of 11 cases of primary adrenocortical carcinoma
10.3760/cma.j.issn.1008-6706.2018.09.004
- VernacularTitle: 原发性肾上腺皮质癌11例临床分析
- Author:
Le LIN
1
;
Yongbao WEI
;
Tao LI
;
Liefu YE
;
Qingguo ZHU
;
Xiangxun GAO
Author Information
1. Department of Urology, Fujian Provincial Hospital, the Teaching Hospital of Fujian Medical University, Fuzhou, Fujian 350001, China
- Publication Type:Journal Article
- Keywords:
Adrenal cortex neoplasms;
Retrospective studies
- From:
Chinese Journal of Primary Medicine and Pharmacy
2018;25(9):1103-1106
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To improve the diagnosis and treatment of primary adrenal cortical carcinoma.
Methods:The clinical and pathological data of 11 patients who diagnosed as primary adrenal cortical carcinoma by pathology were retrospectively analyzed.The median age was 43 years, including 6 males, 5 females.7 cases(63.6%) got the tumor on the left.9 cases(81.8%) presented the maximum diameter of tumor more than 6 cm, and the average maximum diameter was 12.9 cm.All cases had CT or MRI imaging examination.Among most of them, CT showed mixed density lesions, or MRI showed mixed signal.Only 3 cases(27.3%) were considered adrenal cortical cancer through preoperative examinations.
Results:11 patients were treated with surgical treatment.Of them, 9 cases(81.8%) had complete resection of tumor.3 cases were lost to follow-up, while other 8 cases were followed up for 5-58 months.3 cases presented tumor-specific death at 5-15 months after surgery, with each 1 case in AJCC stage Ⅱ, Ⅲ and Ⅳ, respectively.Survive were in 5cases, and 3cases of them were tumor-free survival, while the other 2 cases of them had local recurrence.
Conclusion:Adrenal cortical carcinoma is very difficult to diagnose preoperatively.Adrenal cortical cancer should be considered when tumor size more than 4cm and tumor presenting inhomogeneous enhancement.Then, the surgical treatment should be performed as soon as possible, and as appropriate, chemotherapy and other comprehensive treatment should be given subsequently.Clinical and basic research such as genes test may provide more treatment options for advanced tumors in future.
